Technical Analysis for EDIT - Editas Medicine, Inc.

Grade Last Price % Change Price Change
grade D 28.06 -3.37% -0.98
EDIT closed down 3.37 percent on Wednesday, September 30, 2020, on 1.28 times normal volume. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Flat Down Down
Historical EDIT trend table...

Date Alert Name Type % Chg
Fell Below 200 DMA Bearish 0.00%
Down 3 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction -3.37%
NR7 Range Contraction -3.37%
Inside Day Range Contraction -3.37%
Oversold Stochastic Weakness -3.37%
180 Bearish Setup Bearish Swing Setup -3.71%
Slingshot Bearish Bearish Swing Setup -3.71%
Stochastic Reached Oversold Weakness -3.71%
Older End-of-Day Gignals for EDIT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
200 DMA Support about 17 hours ago
1.5x Volume Pace about 18 hours ago
Down 3% about 18 hours ago
Fell Below 200 DMA about 18 hours ago
Down 2 % about 18 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a (also known as Cpf1) genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases
Biotechnology Biology Immune System Genetic Engineering Enzymes Genome Editing Cas9 CRISPR

Is EDIT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 39.96
52 Week Low 14.01
Average Volume 864,997
200-Day Moving Average 28.20
50-Day Moving Average 32.70
20-Day Moving Average 31.17
10-Day Moving Average 30.79
Average True Range 1.81
ADX 14.08
+DI 18.92
-DI 29.13
Chandelier Exit (Long, 3 ATRs ) 31.12
Chandelier Exit (Short, 3 ATRs ) 33.12
Upper Bollinger Band 35.07
Lower Bollinger Band 27.28
Percent B (%b) 0.1
BandWidth 25.02
MACD Line -1.13
MACD Signal Line -0.75
MACD Histogram -0.3842
Fundamentals Value
Market Cap 1.15 Billion
Num Shares 40.9 Million
EPS -3.17
Price-to-Earnings (P/E) Ratio -8.85
Price-to-Sales 158.87
Price-to-Book 4.84
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 30.58
Resistance 3 (R3) 30.74 30.05 30.16
Resistance 2 (R2) 30.05 29.41 29.98 30.02
Resistance 1 (R1) 29.06 29.02 28.72 28.90 29.88
Pivot Point 28.37 28.37 28.20 28.30 28.37
Support 1 (S1) 27.38 27.73 27.04 27.22 26.24
Support 2 (S2) 26.69 27.34 26.62 26.10
Support 3 (S3) 25.70 26.69 25.96
Support 4 (S4) 25.54